tb500 and igf 1 lr3 IGF-1 Research: Extended Half-Life IGF-1 LR3 Peptide Therapy in
Description
These symptoms correlate with poorer semen parameters
Partial reversibility of growth hormone (GH) deficiency in the GH-releasing hormone (GHRH) knockout mouse by postnatal treatment with a GHRH analog
AR and SH drafted the manuscript
Zhou, E
Chin Med 18(1):114
